Today's Daily Dose brings you news about FDA approval of Adamas' GOCOVRI for an expanded indication, positive results from Arcutis' plaque psoriasis trial, Concert Pharma's disappointing data from schizophrenia trial, and the progress in Clover's phase I adjuvanted trial of COVID-19 S-Trimer vaccine candidates, to name a few.